What is the recommended protocol for NAD (Nicotinamide adenine dinucleotide) infusion or bolus dose in a wellness setting?

NAD Infusion for Wellness Centers: Evidence-Based Guidance

Direct Recommendation

Do not offer intravenous NAD infusions or bolus dosing in your wellness center, as there are no established clinical guidelines supporting this practice, no FDA approval for therapeutic medical indications, and insufficient evidence of clinical benefit. 1

---

Why NAD Infusions Are Not Recommended

Lack of Guideline Support

• The American Academy of Physical Medicine and Rehabilitation explicitly does not recommend NAD administration via patches or infusions due to lack of clinical evidence. 1, 2
• FDA labeling for intravenous NAD lists only cosmetic uses, not therapeutic medical indications. 1
• No professional medical society has published guidelines endorsing NAD infusions for wellness or therapeutic purposes. 1, 2, 3

Poor Pharmacokinetics and Safety Concerns

• High doses of nicotinic acid (a NAD precursor) cause flushing, nausea, vomiting, liver toxicity, blurred vision, and impaired glucose tolerance. 1, 2
• The upper intake level for nicotinic acid is only 10 mg/day due to flushing effects, making higher-dose infusions problematic. 1, 2, 3
• NAD(P)H oxidase activity has been implicated in anthracycline-induced cardiotoxicity, raising concerns about NAD supplementation in certain clinical contexts. 1
• Common adverse events from NAD supplementation include muscle pain, nervous disorders, fatigue, sleep disturbance, and headaches. 4

Limited Clinical Evidence

• While oral NAD precursors (nicotinamide riboside, nicotinamide mononucleotide) are safe and can increase NAD+ levels in tissues, studies show limited efficacy for improving physiological function. 5, 6
• Evidence for age-related NAD+ decline in humans has been consistently observed only in a limited number of studies. 6
• Human clinical trials of NAD+ precursor supplementation have shown limited efficacy despite promising preclinical data. 6
• Small sample sizes, varying dosing regimens, and inconsistent study durations limit interpretation of physiological outcomes. 5

---

Evidence-Based Alternatives for Your Wellness Center

Oral NAD Precursor Supplementation

If clients are interested in NAD enhancement, recommend oral supplementation with established NAD precursors rather than infusions:

• Nicotinamide (preferred form): Upper intake level is approximately 900 mg/day for adults, with no flushing effects and no adverse effects at doses up to 25 mg/kg body weight/day in prolonged studies. 1, 3
• Nicotinamide riboside or nicotinamide mononucleotide: These compounds are safe, tolerable, and can increase NAD+ abundance in multiple tissues. 5
• Oral supplementation is the recommended route whenever the gastrointestinal tract is functional, as it has established safety data and effectively increases blood NAD+ levels. 3

Dietary Recommendations

First-line approach should emphasize dietary sources of niacin: 1, 3

• Meat, poultry, and red fish (tuna, salmon)
• Nuts, legumes, and seeds
• Fortified packaged foods
• Daily dietary reference intakes: 16 mg/day for males, 14 mg/day for females 3

Clinical Algorithm for NAD Enhancement

1. Initial consultation: Recommend dietary sources of niacin as first-line approach. 1

2. If deficiency suspected: Measure blood or tissue NAD levels only in the presence of pellagra symptoms (diarrhea, dermatitis, dementia). 1

3. If deficiency confirmed: Use oral nicotinic acid (15-20 mg/day) or nicotinamide (300 mg/day) for pellagra treatment. 1

4. For wellness optimization without deficiency: Consider oral nicotinamide supplementation (up to 900 mg/day) or nicotinamide riboside/mononucleotide at studied doses. 3, 5

5. Avoid NAD infusion for therapeutic purposes outside of research protocols, given the lack of guideline support, poor pharmacokinetics, and absence of proven clinical benefit. 1

---

Critical Pitfalls to Avoid

Legal and Regulatory Risks

• Offering NAD infusions without FDA approval for therapeutic indications exposes your practice to regulatory scrutiny. 1
• Marketing unproven therapies as wellness treatments may violate consumer protection laws and medical practice standards. 1, 2

Clinical Safety Concerns

• Intravenous administration bypasses normal metabolic regulation and may cause unpredictable adverse effects. 1
• Patients with underlying cardiac conditions may be at increased risk given NAD(P)H oxidase involvement in cardiotoxicity. 1
• Lack of standardized monitoring protocols means you cannot adequately assess safety or efficacy. 3

Ethical Considerations

• The evidence does not support charging patients for NAD infusions when oral supplementation is safer, cheaper, and has more established efficacy data. 1, 5
• Extrapolation of rodent-based NAD+ data to humans is not straightforward, and the published body of data on NAD+ dynamics in human tissues remains sparse. 6

---

If Clients Insist on NAD Enhancement

Offer evidence-based oral supplementation protocols instead:

• Start with dietary optimization emphasizing niacin-rich foods. 1, 3
• Consider oral nicotinamide 300-900 mg/day (no flushing, well-tolerated). 1, 3
• Alternative: nicotinamide riboside or nicotinamide mononucleotide at doses studied in clinical trials (typically 250-1000 mg/day). 5
• Monitor for gastrointestinal symptoms (nausea, vomiting, diarrhea) as potential side effects. 4
• Set realistic expectations: clinical benefits in humans remain uncertain despite preclinical promise. 5, 6